A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity

NCT00231608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.